Get Acquainted

What You Need to Know

close
close
close

Learn about a vaccine
that can help protect
against MenB

Learn more

close
close
close
close
close
close
close
close
close

Learn about a vaccine
that can help protect
against MenB

Learn more

References

  • 1. Centers for Disease Control and Prevention. Meningococcal disease. Centers for Disease Control and Prevention website. http://www.cdc.gov/meningococcal/index.html. Updated March 28, 2017. Accessed June 15, 2017.
  • 2. McNeil LK, Zagursky RJ, Lin SL, et al. Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease. Microbiol Mol Biol Rev. 2013;77(2):234-252.
  • 3. Folaranmi T, Rubin L, Martin SW, et al. Use of serogroup B meningococcal vaccines in persons aged ≥10 years at increased risk for serogroup B meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2015. MMWR. 2015;64(22):608-612.
  • 4. MacNeil JR, Rubin L, Folaranmi T, et al. Centers for Disease Control and Prevention. Use of serogroup B meningococcal vaccines in adolescents and young adults: recommendations of the Advisory Committee on Immunization Practices. MMWR. 2015;64(41):1171-1176.
  • 5. Soeters HM, McNamara LA, Whaley M, et al. Serogroup B meningococcal disease outbreak and carriage evaluation at a college Rhode Island, 2015. MMWR. 2015;64(22):606-607.
  • 6. Centers for Disease Control and Prevention. Meningococcal disease: signs and symptoms: meningococcal meningitis. Centers for Disease Control and Prevention website. http://www.cdc.gov/meningococcal/about/symptoms.html. Updated June 7, 2017. Accessed June 15, 2017.
  • 7. Thompson MJ, Ninis N, Perera R, et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet. 2006;367(9508):397-403.
  • 8. Bettinger JA, Scheifele DW, Le Saux N, et al. The disease burden of invasive meningococcal disease in Canada. Pediatr Infect Dis J. 2013;32(1):e20-e25.